Xeris Biopharma has not yet achieved cash flow breakeven and may no longer be a "Top Idea" in the Compounding Healthcare Investing Group.Xeris has three approved products and a strong pipeline, with ...
Source LinkXeris Biopharma has not yet achieved cash flow breakeven and may no longer be a "Top Idea" in the Compounding Healthcare Investing Group.Xeris has three approved products and a strong pipeline, with ...
Source Link
Comments